参考文献/References:
[1]Hadziyannis SJ,Sevastianos V,Rapti I.Sustained responses and loss of HBsAg in HBeAg-negative patients with chronic hepatitis B who stoplong-term treatment with adefovir[J].Gastroenterology,2012,143(3):629-636.[2]王浩,陈春晖.血清免疫球蛋白在乙型肝炎患者的临床应用价值[J].实验与检验医学,2018,36(6):895-896,905.[3]Stanaway JD,Flaxman AD,Naghavi M,et al.The global burden of viral hepatitis from 1990 to 2013:findings from the Global Burden of Disease Study 2013[J].Lancet,2016,388(10049):1081-1088.[4]郭琪.《人民日报》乙肝报道的议题建构[D].山西大学,2013.[5]龚建平,廖汪洋,何益平.Kupffer细胞与HBV慢性感染引起的肝损伤[J].世界华人消化杂志,2008,16(24):2735-2740.[6]赵瑞斌,赵振江.对丙种球蛋白在临床应用中的再认识[J]. 内科,2007,2(3):381-383.
相似文献/References:
[1]李安乐,戴 夫,彭 琼.中性粒细胞与淋巴细胞比值、红细胞体积分布宽度与乙型肝炎及乙型肝炎肝硬化的关系研究[J].医学信息,2019,32(03):69.[doi:10.3969/j.issn.1006-1959.2019.03.022]
LI An-le,DAI Fu,PENG Qiong.Relationship between Neutrophil-lymphocyte Ratio,Red Blood Cell Volume Distribution Width and Hepatitis B and Hepatitis B Cirrhosis[J].Medical Information,2019,32(13):69.[doi:10.3969/j.issn.1006-1959.2019.03.022]
[2]王媛媛.乙型肝炎患者血清免疫球蛋白检测的意义[J].医学信息,2018,31(18):155.[doi:10.3969/j.issn.1006-1959.2018.18.050]
WANG Yuan-yuan.Significance of Detection of Serum Immunoglobulin in Patients with Hepatitis B[J].Medical Information,2018,31(13):155.[doi:10.3969/j.issn.1006-1959.2018.18.050]
[3]桂志兵,汪文生.红细胞分布宽度与血小板计数比值在乙型肝炎肝硬化患者病情评估中的作用[J].医学信息,2018,31(20):65.[doi:10.3969/j.issn.1006-1959.2018.20.019]
GUI Zhi-bing,WANG Wen-sheng.The Role of Red Blood Cell Distribution Width and Platelet Ratio in the Evaluation of Patients with Hepatitis B Cirrhosis[J].Medical Information,2018,31(13):65.[doi:10.3969/j.issn.1006-1959.2018.20.019]
[4]洪 亮,陶 静,张 静,等.上海市男性同性恋HIV感染者中乙型肝炎、丙型肝炎病毒的合并感染情况横断面研究[J].医学信息,2019,32(06):145.[doi:10.3969/j.issn.1006-1959.2019.06.046]
HONG Liang,TAO Jing,ZHANG Jing,et al.Cross-sectional Study on the Co-infection of Hepatitis B and Hepatitis C Virus among HIV-infected People in Shanghai[J].Medical Information,2019,32(13):145.[doi:10.3969/j.issn.1006-1959.2019.06.046]
[5]裴金仙,陈天狮,任巧晶,等.IL-23在慢性乙型肝炎免疫调节中的作用研究[J].医学信息,2019,32(08):129.[doi:10.3969/j.issn.1006-1959.2019.08.037]
PEI Jin-xian,CHEN Tian-shi,REN Qiao-jing,et al.The Role of IL-23 in the Immune Regulation of Chronic Hepatitis B[J].Medical Information,2019,32(13):129.[doi:10.3969/j.issn.1006-1959.2019.08.037]
[6]方志军.实时荧光PCR检测乙肝病毒DNA的效果评价[J].医学信息,2019,32(22):175.[doi:10.3969/j.issn.1006-1959.2019.22.062]
FANG Zhi-jun.Evaluation of the Effect of Real-time Fluorescent PCR on Detection of Hepatitis B Virus DNA[J].Medical Information,2019,32(13):175.[doi:10.3969/j.issn.1006-1959.2019.22.062]
[7]肖岑昕,黄恒青.肠道微生物群与慢性病毒性肝炎的关系[J].医学信息,2021,34(21):39.[doi:10.3969/j.issn.1006-1959.2021.21.009]
XIAO Cen-xin,HUANG Heng-qing.Relationship Between Intestinal Microflora and Chronic Viral Hepatitis[J].Medical Information,2021,34(13):39.[doi:10.3969/j.issn.1006-1959.2021.21.009]
[8]王明杰,秦玉杰.聚乙二醇干扰素α序贯联合核苷类药物治疗高病毒载量e抗原阳性乙型肝炎的疗效[J].医学信息,2021,34(19):107.[doi:10.3969/j.issn.1006-1959.2021.19.027]
WANG Ming-jie,QIN Yu-jie.Efficacy of Peginterferon α Sequential Combined with Nucleoside Drugs in theTreatment of High Viral Load e Antigen Positive Hepatitis B[J].Medical Information,2021,34(13):107.[doi:10.3969/j.issn.1006-1959.2021.19.027]
[9]孙燕飞.替诺福韦酯治疗乙型肝炎的效果及对复发率的影响[J].医学信息,2024,37(08):121.[doi:10.3969/j.issn.1006-1959.2024.08.024]
SUN Yan-fei.Effect of Tenofovir Disoproxil in the Treatment of Hepatitis B and its Effect on Recurrence Rate[J].Medical Information,2024,37(13):121.[doi:10.3969/j.issn.1006-1959.2024.08.024]
[10]刘金兰.乙肝两对半和DNA联合检验在乙肝诊断中的价值[J].医学信息,2025,38(08):144.[doi:10.3969/j.issn.1006-1959.2025.08.030]
LIU Jinlan.Value of Combined Detection of Hepatitis B Virus Serological Markers and DNA in the Diagnosis of Hepatitis B[J].Medical Information,2025,38(13):144.[doi:10.3969/j.issn.1006-1959.2025.08.030]